OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 108, Issue 2, Pages 343-347 (February 2001)


View previous. 40 of 51 View next.

Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial1

Presented in part at the annual meeting of The Association for Research in Vision and Ophthalmology, May 1998, Fort Lauderdale, Florida.

for the Cryotherapy for Retinopathy of Prematurity Cooperative Group2Graham E. Quinn, MD1Corresponding Author Informationemail address, Velma Dobson, PhD2, R.Michael Siatkowski, MD3, Robert J. Hardy, PhD4, Jane Kivlin, MD5, Earl A. Palmer, MD6, Dale L. Phelps, MD7, Michael X. Repka, MD8, C.Gail Summers, MD9, Betty Tung, MS4, Wenyaw Chan, PhD4

Received 30 December 1999; accepted 12 September 2000.

Abstract 

Purpose

To evaluate the effect of cryotherapy on refractive error status between ages 3 months and 10 years in children with birth weights of less than 1251 g in whom severe retinopathy of prematurity (ROP) developed in one or both eyes during the neonatal period.

Design

Randomized clinical trial.

Participants

Two hundred ninety-one children in whom severe ROP developed during the neonatal period.

Intervention

Cryotherapy for ROP.

Main outcome measures

Cycloplegic Refraction

Methods

The children underwent repeated follow-up eye examinations, including cycloplegic retinoscopy, between 3 months and 10 years after term due date. Refractive error data from all eyes that were randomized to cryotherapy were compared with data from all eyes that were randomized to serve as controls. Refractive error data were also compared for a subset of children who had both a treated and a control eye that could be refracted.

Results

At all ages, the proportion of treated eyes that were unable to be refracted because of retinal detachment, media opacity, or pupillary miosis was approximately half the proportion of the control eyes that were unable to be refracted. When data from all eyes that could be refracted were considered, the distribution of refractive errors between fewer than 8 diopters (D) of myopia and more than 8 D of hyperopia was similar for treated and control eyes at all ages. The proportion of eyes with 8 D or more of myopia was much higher in treated than in control eyes at all ages after 3 months. In the subset of children who had a treated eye and a control eye that could be refracted, distributions of refractive errors in treated versus control eyes were similar at most ages.

Conclusions

In both treated and control eyes, there was an increase in the prevalence of high myopia between 3 and 12 months of age. Between 12 months and 10 years of age, there was little change in distribution of refractive error in treated or control eyes. The higher prevalence of myopia of 8 D or more in treated eyes, as compared with control eyes, may be the result of cryotherapy’s preservation of retinal structure in eyes that, in the absence of cryotherapy, would have progressed to retinal detachment.

Manuscript no. 99855.

1 Division of Pediatric Ophthalmology, The Children’s Hospital of Philadelphia and Scheie Eye Institute, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA

2 Departments of Ophthalmology and Psychology, University of Arizona, Tucson, Arizona, USA

3 Department of Ophthalmology, University of Oklahoma, Oklahoma City, Oklahoma, USA

4 University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, USA

5 Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

6 Casey Eye Institute, Oregon Health Sciences University, Portland, Oregon, USA

7 Departments of Pediatrics and Ophthalmology, University of Rochester, Rochester, New York, USA

8 Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

9 Departments of Ophthalmology and Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA

Corresponding Author InformationCorrespondence to Graham E. Quinn, MD, Division of Pediatric Ophthalmology, The Children’s Hospital of Philadelphia, One Children’s Center, Philadelphia, PA 19104

 Supported by the National Eye Institute, Bethesda, Maryland (cooperative agreement no. U10 EY05874).

1 A listing of cooperative group participants can be found in Archives of Ophthalmology 1996;114:417–24.

2 Reprint requests to CRYO-ROP Study Headquarters, Oregon Health Sciences University, Department of Ophthalmology, L467, 3375 SW Terwilliger Boulevard, Portland, OR 97201-4197 (Earl A. Palmer, MD).

PII: S0161-6420(00)00527-3


View previous. 40 of 51 View next.